share_log

Leerink Partners Downgrades Q32 Bio to Market Perform, Lowers Price Target to $9

Benzinga ·  Dec 11 19:57  · Ratings

Leerink Partners analyst Thomas Smith downgrades Q32 Bio (NASDAQ:QTTB) from Outperform to Market Perform and lowers the price target from $68 to $9.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment